{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T04:27:40Z","timestamp":1740112060486,"version":"3.37.3"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012599","name":"Bethlehem Griffiths Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012599","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ejpb.2024.114434","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:21:57Z","timestamp":1722644517000},"page":"114434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Plasma, brain and spinal cord concentrations of caffeine are reduced in the SOD1G93A mouse model of amyotrophic lateral sclerosis following oral administration"],"prefix":"10.1016","volume":"203","author":[{"given":"Liam M.","family":"Koehn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6972-9858","authenticated-orcid":false,"given":"Roshan","family":"Jalaldeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Pelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0983-7152","authenticated-orcid":false,"given":"Joseph A.","family":"Nicolazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2024.114434_b0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2024.114434_b0010","first-page":"185","article-title":"Palliative care for patients with MND\/ALS","volume":"11","author":"Oliver","year":"2004","journal-title":"Eur. J. Palliat. Care"},{"key":"10.1016\/j.ejpb.2024.114434_b0015","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/bph.15802","article-title":"Altered blood\u2013brain barrier and blood\u2013spinal cord barrier dynamics in amyotrophic lateral sclerosis: Impact on medication efficacy and safety","volume":"179","author":"Pan","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejpb.2024.114434_b0020","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1212\/WNL.0b013e3181a41228","article-title":"Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS","volume":"72","author":"Henkel","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ejpb.2024.114434_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-021-01244-0","article-title":"Blood-spinal cord barrier leakage is independent of motor neuron pathology in ALS","volume":"9","author":"Waters","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ejpb.2024.114434_b0030","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.brainres.2009.09.018","article-title":"Impaired blood\u2013brain and blood\u2013spinal cord barriers in mutant SOD1-linked ALS rat","volume":"1301","author":"Nicaise","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.ejpb.2024.114434_b0035","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nn2073","article-title":"ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration","volume":"11","author":"Zhong","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejpb.2024.114434_b0040","series-title":"The ADME Encyclopedia: A Comprehensive Guide on Biopharmacy and Pharmacokinetics","first-page":"11","article-title":"ABC transporters: drug transfer across cellular interfaces","author":"Koehn","year":"2022"},{"key":"10.1016\/j.ejpb.2024.114434_b0045","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nbd.2012.03.040","article-title":"Selective increase of two ABC drug efflux transporters at the blood\u2013spinal cord barrier suggests induced pharmacoresistance in ALS","volume":"47","author":"Jablonski","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejpb.2024.114434_b0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/archneur.1987.00520130079022","article-title":"Hepatic ultrastructural changes and liver dysfunction in amyotrophic lateral sclerosis","volume":"44","author":"Nakano","year":"1987","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ejpb.2024.114434_b0055","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3390\/biomedicines9070753","article-title":"The gut microbiota-immunity axis in ALS: a role in deciphering disease heterogeneity?","volume":"9","author":"Niccolai","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejpb.2024.114434_b0060","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1021\/acs.molpharmaceut.3c01089","article-title":"Sex-dependent changes to the intestinal and hepatic abundance of drug transporters and metabolising enzymes in the SOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"21","author":"Koehn","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2024.114434_b0065","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000491392","article-title":"Relationship between liver pathology and disease progression in a murine model of amyotrophic lateral sclerosis","volume":"18","author":"Lee","year":"2018","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.ejpb.2024.114434_b0070","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12356","article-title":"Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model","volume":"3","author":"Wu","year":"2015","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.ejpb.2024.114434_b0075","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1021\/acs.molpharmaceut.9b01227","article-title":"Intestinal permeability and oral absorption of selected drugs are reduced in a mouse model of familial Alzheimer\u2019s disease","volume":"17","author":"Jin","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2024.114434_b0080","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1021\/acs.molpharmaceut.8b00500","article-title":"Altered expression of small intestinal drug transporters and hepatic metabolic enzymes in a mouse model of familial Alzheimer\u2019s disease","volume":"15","author":"Pan","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2024.114434_b0085","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/jnnp-2020-322938","article-title":"Symptomatic pharmacotherapy in ALS: data analysis from a platform-based medication management programme","volume":"91","author":"Meyer","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ejpb.2024.114434_b0090","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1159\/000007708","article-title":"Noninvasive 13C-octanoic acid breath test shows delayed gastric emptying in patients with amyotrophic lateral sclerosis","volume":"60","author":"Toepfer","year":"1999","journal-title":"Digestion"},{"key":"10.1016\/j.ejpb.2024.114434_b0095","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0140-6736(88)90467-9","article-title":"Xenobiotic metabolism in motorneuron disease","volume":"332","author":"Steventon","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.ejpb.2024.114434_b0100","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11916-008-0052-z","article-title":"Caffeine and headaches","volume":"12","author":"Shapiro","year":"2008","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.ejpb.2024.114434_b0105","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1038\/sj.bjp.0704668","article-title":"Resolution of P-glycoprotein and non-P-glycoprotein effects on drug permeability using intestinal tissues from mdr1a (\u2212\/\u2212) mice","volume":"135","author":"Stephens","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejpb.2024.114434_b0110","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1021\/js9901763","article-title":"Physiologically based pharmacokinetics of digoxin in mdr1a knockout mice","volume":"88","author":"Kawahara","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2024.114434_b0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/mp050113v","article-title":"Breast cancer resistance protein (bcrp\/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse","volume":"3","author":"Zaher","year":"2006","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2024.114434_b0120","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3109\/17482968.2012.662688","article-title":"Effect of genetic background on onset and disease progression in the SOD1-G93A model of amyotrophic lateral sclerosis","volume":"13","author":"Mancuso","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.ejpb.2024.114434_b0125","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.1038\/s41598-019-42402-8","article-title":"Developmental differences in the expression of ABC transporters at rat brain barrier interfaces following chronic exposure to diallyl sulfide","volume":"9","author":"Koehn","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2024.114434_b0130","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/ar.1091990412","article-title":"Methods for the isolation of intact epithelium from the mouse intestine","volume":"199","author":"Bjerknes","year":"1981","journal-title":"Anat. Rec."},{"key":"10.1016\/j.ejpb.2024.114434_b0135","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1021\/acs.molpharmaceut.6b00514","article-title":"Regional intestinal permeability of three model drugs in human","volume":"13","author":"Dahlgren","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2024.114434_b0140","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1021\/js970332a","article-title":"Human intestinal permeability","volume":"87","author":"Lennerna\u00e4s","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2024.114434_b0145","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13654","article-title":"Sexual dimorphism in upper gastrointestinal motility is dependent on duration of fast, time of day, age, and strain of mice","volume":"31","author":"Soni","year":"2019","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.ejpb.2024.114434_b0150","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF01062139","article-title":"Testing for the equality of area under the curves when using destructive measurement techniques","volume":"16","author":"Bailer","year":"1988","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ejpb.2024.114434_b0155","doi-asserted-by":"crossref","first-page":"9094","DOI":"10.1038\/s41598-017-09097-1","article-title":"Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study","volume":"7","author":"Hu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2024.114434_b0160","doi-asserted-by":"crossref","unstructured":"L. Koehn, M. Habgood, Y. Huang, K. Dziegielewska, N. Saunders. (2019) Determinants of drug entry into the developing brain, F1000Research, 8.","DOI":"10.12688\/f1000research.20078.1"},{"key":"10.1016\/j.ejpb.2024.114434_b0165","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/mus.21160","article-title":"Progressive motor unit loss in the G93A mouse model of amyotrophic lateral sclerosis is unaffected by gender","volume":"39","author":"Hegedus","year":"2009","journal-title":"Muscle & Nerve: Official J. American Association of Electrodiagnostic Medicine"},{"key":"10.1016\/j.ejpb.2024.114434_b0170","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.genm.2010.11.010","article-title":"Effects of gender in amyotrophic lateral sclerosis","volume":"7","author":"McCombe","year":"2010","journal-title":"Gend. Med."},{"key":"10.1016\/j.ejpb.2024.114434_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117543","article-title":"Bowel, bladder, and sudomotor symptoms in ALS patients","volume":"427","author":"Samara","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ejpb.2024.114434_b0180","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/146608299300079484","article-title":"M, Gastrointestinal dysfunction in amyotrophic lateral sclerosis","volume":"1","author":"Toepfer","year":"2000","journal-title":"Amyotroph. Lateral Scler. Other Motor Neuron Disord."},{"key":"10.1016\/j.ejpb.2024.114434_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.752826","article-title":"Pharmacokinetics of caffeine: A systematic analysis of reported data for application in metabolic phenotyping and liver function testing","volume":"12","author":"Grzegorzewski","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2024.114434_b0190","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.clinthera.2023.09.025","article-title":"Pharmacokinetics of edaravone oral suspension in patients with amyotrophic lateral sclerosis","volume":"45","author":"Shimizu","year":"2023","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejpb.2024.114434_b0195","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.3390\/pharmaceutics14122803","article-title":"Altered blood\u2013brain barrier dynamics in the C9orf72 hexanucleotide repeat expansion mouse model of amyotrophic lateral sclerosis","volume":"14","author":"Pan","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2024.114434_b0200","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neulet.2010.01.078","article-title":"P-glycoprotein expression and function are increased in an animal model of amyotrophic lateral sclerosis","volume":"472","author":"Milane","year":"2010","journal-title":"Neurosci. Lett."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124002601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124002601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T05:18:58Z","timestamp":1730092738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641124002601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":40,"alternative-id":["S0939641124002601"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114434","relation":{},"ISSN":["0939-6411"],"issn-type":[{"type":"print","value":"0939-6411"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma, brain and spinal cord concentrations of caffeine are reduced in the SOD1G93A mouse model of amyotrophic lateral sclerosis following oral administration","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114434"}}